Cargando…

Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes

Intrahost genetic diversity is thought to facilitate arbovirus adaptation to changing environments and hosts, and it might also be linked to viral pathogenesis. Dengue virus serotype 2 (DENV-2) has circulated in Brazil since 1990 and is associated with severe disease and explosive outbreaks. Intendi...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres, Maria Celeste, Lima de Mendonça, Marcos Cesar, Damasceno dos Santos Rodrigues, Cintia, Fonseca, Vagner, Ribeiro, Mario Sergio, Brandão, Ana Paula, Venâncio da Cunha, Rivaldo, Dias, Ana Isabel, Santos Vilas Boas, Lucy, Felix, Alvina Clara, Alves Pereira, Maira, de Oliveira Pinto, Luzia Maria, Sakuntabhai, Anavaj, Bispo de Filippis, Ana Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926750/
https://www.ncbi.nlm.nih.gov/pubmed/33672226
http://dx.doi.org/10.3390/v13020349
_version_ 1783659533575389184
author Torres, Maria Celeste
Lima de Mendonça, Marcos Cesar
Damasceno dos Santos Rodrigues, Cintia
Fonseca, Vagner
Ribeiro, Mario Sergio
Brandão, Ana Paula
Venâncio da Cunha, Rivaldo
Dias, Ana Isabel
Santos Vilas Boas, Lucy
Felix, Alvina Clara
Alves Pereira, Maira
de Oliveira Pinto, Luzia Maria
Sakuntabhai, Anavaj
Bispo de Filippis, Ana Maria
author_facet Torres, Maria Celeste
Lima de Mendonça, Marcos Cesar
Damasceno dos Santos Rodrigues, Cintia
Fonseca, Vagner
Ribeiro, Mario Sergio
Brandão, Ana Paula
Venâncio da Cunha, Rivaldo
Dias, Ana Isabel
Santos Vilas Boas, Lucy
Felix, Alvina Clara
Alves Pereira, Maira
de Oliveira Pinto, Luzia Maria
Sakuntabhai, Anavaj
Bispo de Filippis, Ana Maria
author_sort Torres, Maria Celeste
collection PubMed
description Intrahost genetic diversity is thought to facilitate arbovirus adaptation to changing environments and hosts, and it might also be linked to viral pathogenesis. Dengue virus serotype 2 (DENV-2) has circulated in Brazil since 1990 and is associated with severe disease and explosive outbreaks. Intending to shed light on the viral determinants for severe dengue pathogenesis, we sought to analyze the DENV-2 intrahost genetic diversity in 68 patient cases clinically classified as dengue fever (n = 31), dengue with warning signs (n = 19), and severe dengue (n = 18). Unlike previous DENV intrahost diversity studies whose approaches employed PCR, here we performed viral whole-genome deep sequencing from clinical samples with an amplicon-free approach, representing the real intrahost diversity scenario. Striking differences were detected in the viral population structure between the three clinical categories, which appear to be driven mainly by different infection times and selection pressures, rather than being linked with the clinical outcome itself. Diversity in the NS2B gene, however, showed to be constrained, irrespective of clinical outcome and infection time. Finally, 385 non-synonymous intrahost single-nucleotide variants located along the viral polyprotein, plus variants located in the untranslated regions, were consistently identified among the samples. Of them, 124 were exclusively or highly detected among cases with warning signs and among severe cases. However, there was no variant that by itself appeared to characterize the cases of greater severity, either due to its low intrahost frequency or the conservative effect on amino acid substitution. Although further studies are necessary to determine their real effect on viral proteins, this heightens the possibility of epistatic interactions. The present analysis represents an initial effort to correlate DENV-2 genetic diversity to its pathogenic potential and thus contribute to understanding the virus’s dynamics within its human host.
format Online
Article
Text
id pubmed-7926750
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79267502021-03-04 Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes Torres, Maria Celeste Lima de Mendonça, Marcos Cesar Damasceno dos Santos Rodrigues, Cintia Fonseca, Vagner Ribeiro, Mario Sergio Brandão, Ana Paula Venâncio da Cunha, Rivaldo Dias, Ana Isabel Santos Vilas Boas, Lucy Felix, Alvina Clara Alves Pereira, Maira de Oliveira Pinto, Luzia Maria Sakuntabhai, Anavaj Bispo de Filippis, Ana Maria Viruses Article Intrahost genetic diversity is thought to facilitate arbovirus adaptation to changing environments and hosts, and it might also be linked to viral pathogenesis. Dengue virus serotype 2 (DENV-2) has circulated in Brazil since 1990 and is associated with severe disease and explosive outbreaks. Intending to shed light on the viral determinants for severe dengue pathogenesis, we sought to analyze the DENV-2 intrahost genetic diversity in 68 patient cases clinically classified as dengue fever (n = 31), dengue with warning signs (n = 19), and severe dengue (n = 18). Unlike previous DENV intrahost diversity studies whose approaches employed PCR, here we performed viral whole-genome deep sequencing from clinical samples with an amplicon-free approach, representing the real intrahost diversity scenario. Striking differences were detected in the viral population structure between the three clinical categories, which appear to be driven mainly by different infection times and selection pressures, rather than being linked with the clinical outcome itself. Diversity in the NS2B gene, however, showed to be constrained, irrespective of clinical outcome and infection time. Finally, 385 non-synonymous intrahost single-nucleotide variants located along the viral polyprotein, plus variants located in the untranslated regions, were consistently identified among the samples. Of them, 124 were exclusively or highly detected among cases with warning signs and among severe cases. However, there was no variant that by itself appeared to characterize the cases of greater severity, either due to its low intrahost frequency or the conservative effect on amino acid substitution. Although further studies are necessary to determine their real effect on viral proteins, this heightens the possibility of epistatic interactions. The present analysis represents an initial effort to correlate DENV-2 genetic diversity to its pathogenic potential and thus contribute to understanding the virus’s dynamics within its human host. MDPI 2021-02-23 /pmc/articles/PMC7926750/ /pubmed/33672226 http://dx.doi.org/10.3390/v13020349 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Torres, Maria Celeste
Lima de Mendonça, Marcos Cesar
Damasceno dos Santos Rodrigues, Cintia
Fonseca, Vagner
Ribeiro, Mario Sergio
Brandão, Ana Paula
Venâncio da Cunha, Rivaldo
Dias, Ana Isabel
Santos Vilas Boas, Lucy
Felix, Alvina Clara
Alves Pereira, Maira
de Oliveira Pinto, Luzia Maria
Sakuntabhai, Anavaj
Bispo de Filippis, Ana Maria
Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes
title Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes
title_full Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes
title_fullStr Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes
title_full_unstemmed Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes
title_short Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes
title_sort dengue virus serotype 2 intrahost diversity in patients with different clinical outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926750/
https://www.ncbi.nlm.nih.gov/pubmed/33672226
http://dx.doi.org/10.3390/v13020349
work_keys_str_mv AT torresmariaceleste denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT limademendoncamarcoscesar denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT damascenodossantosrodriguescintia denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT fonsecavagner denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT ribeiromariosergio denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT brandaoanapaula denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT venanciodacunharivaldo denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT diasanaisabel denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT santosvilasboaslucy denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT felixalvinaclara denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT alvespereiramaira denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT deoliveirapintoluziamaria denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT sakuntabhaianavaj denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT bispodefilippisanamaria denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes
AT denguevirusserotype2intrahostdiversityinpatientswithdifferentclinicaloutcomes